Detalhe da pesquisa
1.
Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy.
JAC Antimicrob Resist
; 4(5): dlac104, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36237571